Screener
Gossamer Bio, Inc. GOSS Q1 2025 earnings
Reported May 15, 2025 · After market close
Revenue$9.9MBeat by $5.9M
EPS-$0.16Beat by $0.02
Revenue estimate$3.9M
EPS estimate-$0.18
Next report
Nov 4, 2026 (in 2 months)Revenue estimate$10.7M
EPS estimate-$3.81
Versus estimates
Revenue
Diluted EPS
FAQ
- When did Gossamer Bio, Inc. report Q1 2025 earnings?
- Gossamer Bio, Inc. (GOSS) reported Q1 2025 earnings on May 15, 2025 after market close.
- What were Gossamer Bio, Inc.'s Q1 2025 revenue and EPS?
- Gossamer Bio, Inc. reported revenue of $9.9M and eps of $-0.16 for Q1 2025.
- Did Gossamer Bio, Inc. beat estimates in Q1 2025?
- Revenue beat the consensus estimate of $3.9M by $5.9M. EPS beat the consensus estimate of $-0.18 by $0.02.
- How did Gossamer Bio, Inc.'s Q1 2025 results compare year-over-year?
- Compared to the same quarter a year prior, eps grew 15.8% from $-0.19.
- Where can I find Gossamer Bio, Inc.'s Q1 2025 SEC filings?
- You can read the 8-K earnings release (0001728117-25-000037) and the 10-Q periodic report (0001728117-25-000036) directly on SEC EDGAR. The filing index links above go to sec.gov.
